Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05170438
What this trial is testing

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

Who this might be right for
Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan 51
Early research (Phase 1)Study completedNCT00626158
What this trial is testing

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Who this might be right for
Pancreatic CancerBiliary Cancer
University of California, San Francisco 45
Testing effectiveness (Phase 2)WithdrawnNCT06084689
What this trial is testing

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures

Who this might be right for
Adult Soft Tissue SarcomaNon Small Cell Lung CancerTriple Negative Breast Cancer+2 more
Institut Bergonié
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729917
What this trial is testing

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Who this might be right for
Bile Duct CarcinomaCholangiocarcinoma
Zhejiang University 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07723534
What this trial is testing

Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Midhun Malla 32
Testing effectiveness (Phase 2)Looking for participantsNCT05222971
What this trial is testing

Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy

Who this might be right for
Biliary Tract CancerDNA Damage Repair Deficiency
Asan Medical Center 62
Large-scale testing (Phase 3)Ended earlyNCT04163900
What this trial is testing

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
NuCana plc 773
Not applicableStudy completedNCT05114369
What this trial is testing

Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma Gallbladder

Who this might be right for
Gall Bladder CarcinomaSurvival
Sanjay Gandhi Postgraduate Institute of Medical Sciences 48
Large-scale testing (Phase 3)UnknownNCT01755013
What this trial is testing

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary StrictureBiliary Obstruction+1 more
Weill Medical College of Cornell University 55
Large-scale testing (Phase 3)Ended earlyNCT04066491
What this trial is testing

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 309
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Testing effectiveness (Phase 2)UnknownNCT04837508
What this trial is testing

MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Advanced or Metastatic Biliary Tract Cancer
Shanghai Miracogen Inc. 86
Testing effectiveness (Phase 2)UnknownNCT05559775
What this trial is testing

A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy

Who this might be right for
Gastrointestinal Cancer
Zhejiang Cancer Hospital 20
Not applicableStudy completedNCT05028439
What this trial is testing

RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First People's Hospital of Hangzhou 70
Large-scale testing (Phase 3)Looking for participantsNCT06622057
What this trial is testing

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
InnoPharmax Inc. 240
Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Testing effectiveness (Phase 2)Looking for participantsNCT06529718
What this trial is testing

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Who this might be right for
Biliary Tract Cancer
UNICANCER 72
Next Page